Advanced MRI scans to find high risk areas in brain tumors
Original title: Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, so it is still a test.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests special MRI scans that may show where a brain tumor is most likely to come back.
Who this trial is for. This study is for people with malignant glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary, a type of brain tumor. It also looks at other solid tumors. It tests advanced MR imaging to spot areas at high risk of coming back.
Where it stands. The study is checking if this imaging is safe and causes few or mild side effects. It is also looking at changes in chemicals inside tumors. The trial has not reported results yet.
What this means, and what it doesn't
What it could mean: Better scans could one day help doctors plan radiation. Someone who fits might ask their care team about this study.
What it doesn't mean: This does not mean the imaging is proven to help. A trial is a test, not a treatment we know works. Joining a trial does not promise any benefit. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.